Information for Medical Trainees

Hematology Residency Training Program

The Hematology Residency Training Program is proud to provide an extremely strong training experience. The residents who complete our program are fully prepared to excel in independent practice.

We have a world-class Bone Marrow Transplant Program as well as an internationally renowned Thrombosis Program with impressive research funding and productivity.  We provide a great degree of flexibility in the Residency Training Program in order to meet the career needs of our candidates, with significant elective time for each resident to individualize their program based on their particular interests.

The division is extremely supportive of the Hematology Training Program with a strong commitment to education and the CanMEDS philosophy.  Strengths of our educational program include a rigorous academic curriculum, a culture of ongoing formative evaluation and unique longitudinal clinics that teach residents to become independent medical experts in hematology. Our graduates have established successful careers with a wide range of interests including community hematology, basic science research, clinical research and academic practice with many becoming internationally recognized leaders in their fields.

 Thrombosis Fellowship Program

The Thrombosis Clinical Fellowship program of the Division of Hematology at the University of Ottawa is based in an active, academic, tertiary care subspecialty service. The Thrombosis Program and its members are engaged in a wide variety of innovative clinical and research activities in the areas of (1) Diagnosis and treatment of venous and arterial thromboembolic disease and (2) Management of thrombophilia. Areas of research activity include basic science, clinical health, economic and outcomes research.

The objectives of the Clinical Fellowship are to train high level specialists in thrombosis. The fellows are expected to develop an in-depth knowledge of the physiology, pathology, diagnosis and treatment of thrombotic diseases through a variety of activities, including direct inpatient and outpatient care, clinical and basic research and other academic activities.

The Thrombosis Program at the Ottawa Hospital runs daily Thrombosis Clinics (365 days/year) with referrals from Ottawa and surrounding communities. There are approximately 13,000 visits per year for investigation or treatment for venous thrombosis, thrombophilia or anticoagulation management. In addition, we provide consult service to > 1000 in-patients at 2 campuses of the Ottawa Hospital (~1000 patient beds). The expectation is that at the end of training you will be able to perform as an expert thrombosis consultant.

Educational and Training Objectives

The general objective for the fellows is to acquire clinical skills pertaining to the diagnosis and treatment of thrombotic diseases including but not limited to diagnosis (clinical, lab and imaging) of deep vein thrombosis, pulmonary embolism, other thrombotic disease, thrombophilia (acquired and genetic) and peri-operative anticoagulation.

Specific objectives are to demonstrate expertise in:

  • The use of spiral CT scan for the diagnosis of PE, VQ scan for the diagnosis of PE, ultrasound for the diagnosis of DVT, Spiral CT and venography.
  • Laboratory and clinical diagnosis and management implications of Protein C, S and AT deficiency, Factor V Leiden, Prothrombin Gene variant, Hyperhomocysteinemia and Antiphospholipid antibody syndrome.
  • Laboratory diagnosis and clinical management of HIT.
  • Known indications, complications and limitations for IVC filters ‚Äď permanent and retrievable.
  • Duration of anticoagulation for thrombotic disease including DVT and PE.
  • The diagnosis and therapeutic management of mesenteric vein thrombosis, cerebral sinus thrombosis, central retinal artery and central retinal vein occlusion.
  • The diagnosis and management of thromboembolism in pregnancy.
  • The diagnosis, risk stratification and anticoagulation for atrial fibrillation, peripheral arterial disease and stroke.
  • Order to counsel patients on birth control and thrombosis and hormone replacement therapy and thrombosis.
  • Anticoagulant medications, including reversal of anticoagulation (indications and tools), Warfarin dosing induction and maintenance, and the role of thrombolytics for pulmonary embolism and deep vein thrombosis,
  • Post-phlebitic syndrome, diagnosis and management.
  • Diagnosis and management of heparin allergies and warfarin allergies.

Evaluation Criteria

The fellows will be evaluated on the basis of their accomplishment of the objectives outlined above using a daily appraisal of the fellow’s skills as well as a formal appraisal of the academic activities in which he will be involved (i.e. rounds).

In order to standardize evaluations for trainees within the Division of Hematology, Thrombosis Fellows will be evaluated using the electronic One45 system through the University of Ottawa. Evaluations for outpatient clinics will occur every 6 months and for in-patient services will be completed monthly. Individual meetings with Thrombosis Fellows will take place every 6 months to review and discuss the evaluations.

At the end of the fellowship clinical fellows should be able to:

  • Describe the physiology and pathophysiology of the thrombotic diseases as well as the conditions leading to their development, including in-depth knowledge of thrombophilic states.
  • Describe the clinical characteristics and the key aspects for diagnosis of thrombotic diseases. The fellow is expected to adequately order and interpret all diagnostic studies for thrombotic diseases.
  • Provide adequate treatment and follow up to patients with thrombotic diseases.
  • Describe and provide advice on the prognosis and complications of thrombotic diseases.
  • Describe the epidemiological aspects of thrombotic diseases.
  • Interact with and provide advice to other medical specialists regarding thrombotic diseases in different fields of medicine.


Malignant Hematology Fellowship Program

 < More info coming soon >



Hematology Residency Thrombosis Fellowship  Malignant Hematology Fellowship 
Program Director  Dr. Andrea Kew  Dr. Marc Carrier  Dr. Arleigh McCurdy
Telephone  (613) 737-8899 x 71281  (613) 737-8899 x 73034  (613) 737-8899 x 71281
Assistant  Kim Hutson-Ladouceur  Cathy McSheffery Kim Hutson-Ladouceur


Education Coordinator: Alycia-Anne Martin